Forward Looking Statements

Statements on this website may include forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended. These statements relate to future events or our future performance, rather than historical facts. The terms “aim,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “ongoing,” “plan,” “predict,” “project,” “potential,” “seek,” “should,” “will,” or “would,” and or the negative of these terms, or other comparable terminology intended to identify statements about the future are intended to identify forward-looking statements.  Forward-looking statements include, but are not limited to, statements regarding our strategies, prospects, plans, expectations or objectives of management for our future operations; the potential benefits of our product(s) and product candidate(s); the initiation, timing and potential of planned or ongoing clinical trials for our product candidate(s), including the timing for data readouts; our ability to protect our intellectual property rights, our anticipated operations, financial position, ability to raise capital to fund operations, revenues, costs or expenses. Drug development and commercialization involve a high degree of risk and results in clinical trials may not be indicative of full results, or results from later-stage trials.

Results from any trial do not guarantee regulatory approval and you should not place undue reliance on these statements. These forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including: changes in our strategies, prospects, plans, expectations or objectives for future operations; our ability to successfully implement our corporate strategy; the competitive landscape for our product candidate(s); risks associated with management and key personnel; costs related to clinical trials and product development; the potential benefits of our product(s), including as compared to our competitors’ product(s) and product candidate(s); the initiation, timing and potential of planned or ongoing clinical trials for our product(s), including the timing for data readouts; our ability to successfully commercialize our product(s) and product candidate(s), if approved; the rate of market acceptance, pricing regulations and reimbursement practices from third-party payors or healthcare reform initiatives in the United States and abroad; the availability of future financing; the accuracy of our estimates regarding our expenses, future revenues and capital requirements; developments and projections relating to our competitors, our industry or the market opportunities for our product candidate(s); regulatory, political, environmental, economic and public health developments in the United States and foreign countries, including the decisions made by regulatory authorities; our ability to maintain and protect our data and intellectual property rights; and those factors that we have filed or will file in our reports with the U.S. Securities and Exchange Commission. In addition to the risks identified above, there may be additional risks that we do not currently anticipate or that we currently deem immaterial that could also cause actual results to differ materially from those expressed in our forward-looking statements.

You should not place undue reliance on forward-looking statements. These statements speak only as of the date they are posted to this website and are based on management’s current beliefs and assumptions and the information currently available to them. Many of the risks and uncertainties are outside of management’s control.

We do not undertake any obligation to update any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by applicable law.